• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过聚合酶链反应和直接测序检测人膀胱癌异种移植瘤中Ki-ras基因的罕见点突变。

Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.

作者信息

Grimmond S M, Raghavan D, Russell P J

机构信息

Urological Cancer Research Unit, Royal Prince Alfred Hospital, Sydney, Australia.

出版信息

Urol Res. 1992;20(2):121-6. doi: 10.1007/BF00296523.

DOI:10.1007/BF00296523
PMID:1553789
Abstract

This paper represents the first report of a codon 59 mutation in Ki-ras from a spontaneous human transitional cell carcinoma of the bladder. Point mutations have the potential to activate the ras genes if they occur in critical coding regions. These include the sequences of codons 12, 13, 59, 61 and 63. Mutations in codons 12, 13 and 61 have been reported in a wide variety of human cancers, including transitional cell carcinoma of the bladder. However mutations in codon 59 have been reported only in retroviral Ki-ras and as a result of in vitro mutagenesis experiments. We have used the polymerase chain reaction and direct sequencing to detect mutations of Ki-ras, and allele-specific restriction analysis to detect mutations of N-ras in xenografts and continuous cell lines established from bladder cancer biopsies of ten different patients as well as in direct biopsy specimens from five human bladder tumours. For studies of Ki-ras, a 139 bp fragment which spanned the critical codons 12 and 13 and a 128 bp fragment that spanned the sequences of codon 59, 61 and 63 were enzymatically amplified and then sequenced. No N-ras mutations were detected. A heterozygous mutation of Ki-ras at codon 59 GCA----G/ACA was detected in one line. This mutation is being expressed and appears stable as it was detected over several xenograft passages and was present in paraffin-embedded tissue from the primary tumour of the patient. The biological significance of the mutation in bladder cancer is currently under study.

摘要

本文首次报道了在一例人类膀胱自发性移行细胞癌中检测到Ki-ras基因第59位密码子的突变。如果点突变发生在关键编码区,就有可能激活ras基因。这些关键编码区包括第12、13、59、61和63位密码子的序列。第12、13和61位密码子的突变已在多种人类癌症中报道过,包括膀胱移行细胞癌。然而,第59位密码子的突变仅在逆转录病毒Ki-ras中以及体外诱变实验中被报道过。我们利用聚合酶链反应和直接测序来检测Ki-ras的突变,并利用等位基因特异性限制性分析来检测N-ras的突变,这些检测是在从10名不同患者的膀胱癌活检样本建立的异种移植瘤和连续细胞系以及5例人类膀胱肿瘤的直接活检标本中进行的。对于Ki-ras的研究,一个跨越关键密码子12和13的139bp片段以及一个跨越密码子59、61和63序列的128bp片段被酶促扩增然后测序。未检测到N-ras突变。在一个细胞系中检测到Ki-ras基因第59位密码子GCA----G/ACA的杂合突变。这种突变正在表达,并且看起来是稳定的,因为在多次异种移植传代中都检测到了它,并且在患者原发肿瘤的石蜡包埋组织中也存在。目前正在研究该突变在膀胱癌中的生物学意义。

相似文献

1
Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing.通过聚合酶链反应和直接测序检测人膀胱癌异种移植瘤中Ki-ras基因的罕见点突变。
Urol Res. 1992;20(2):121-6. doi: 10.1007/BF00296523.
2
Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.通过直接测序检测人类膀胱癌中H-ras突变的频率。
Br J Urol. 1994 May;73(5):516-21. doi: 10.1111/j.1464-410x.1994.tb07636.x.
3
Activation of RAS family genes in urothelial carcinoma.尿路上皮癌中RAS家族基因的激活
J Urol. 2009 May;181(5):2312-9. doi: 10.1016/j.juro.2009.01.011. Epub 2009 Mar 19.
4
Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Teratog Carcinog Mutagen. 1993;13(5):225-33. doi: 10.1002/tcm.1770130504.
5
Detection of H-ras gene point mutations in transitional cell carcinoma of human urinary bladder using polymerase chain reaction.
Keio J Med. 1992 Jun;41(2):80-6. doi: 10.2302/kjm.41.80.
6
Screening of H-ras gene point mutations in 50 cases of bladder carcinoma.
Int J Urol. 1997 Mar;4(2):178-85. doi: 10.1111/j.1442-2042.1997.tb00167.x.
7
Mutations of RAS gene family in specimens of bladder cancer.膀胱癌标本中RAS基因家族的突变
Urol J. 2008 Fall;5(4):237-42.
8
Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.膀胱移行细胞癌中Ha-ras和Ki-ras癌基因的低频突变
Anticancer Res. 1998 Jul-Aug;18(4A):2675-8.
9
Analysis of ras gene mutations in gastrointestinal cancers.
J Formos Med Assoc. 1991 Dec;90(12):1149-54.
10
H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.H-RAS突变是小儿膀胱尿路上皮癌的关键分子特征。三例病例的详细报告。
J Pediatr Urol. 2016 Apr;12(2):91.e1-7. doi: 10.1016/j.jpurol.2015.08.020. Epub 2015 Oct 22.

引用本文的文献

1
Therapeutic Response of Metastatic Colorectal Cancer Harboring a Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab.携带错义突变的转移性结直肠癌在与表皮生长因子受体(EGFR)抑制剂帕尼单抗联合化疗后的治疗反应
J Natl Compr Canc Netw. 2017 Apr;15(4):427-432. doi: 10.6004/jnccn.2017.0043.
2
Genetics of Bladder Malignant Tumors in Childhood.儿童膀胱恶性肿瘤的遗传学
Curr Genomics. 2016 Feb;17(1):14-32. doi: 10.2174/1389202916666151014221954.
3
K-RAS mutation in transitional cell carcinoma of urinary bladder.

本文引用的文献

1
Rapid Screening of Mutant N-ras Alleles by Analysis of PCR-Induced Restriction Sites: Allele Specific Restriction Analysis (ASRA).通过分析PCR诱导的限制性酶切位点快速筛选突变型N-ras等位基因:等位基因特异性限制性分析(ASRA)
Leuk Lymphoma. 1991;3(4):293-300. doi: 10.3109/10428199109107917.
2
Analysis of the transforming potential of the human H-ras gene by random mutagenesis.通过随机诱变分析人类H-ras基因的转化潜力。
Proc Natl Acad Sci U S A. 1984 Jul;81(13):4008-12. doi: 10.1073/pnas.81.13.4008.
3
Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene.
膀胱移行细胞癌中的K-RAS突变
Int Urol Nephrol. 2001;33(2):363-7. doi: 10.1023/a:1015213713048.
4
Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.胰腺腺癌中K-ras突变与p53畸变联合存在的患病率及临床意义
Int J Pancreatol. 1997 Apr;21(2):127-43. doi: 10.1007/BF02822384.
人类Ki-ras原癌基因及一个相关的加工假基因的结构与组织
Nature. 1983;304(5926):501-6. doi: 10.1038/304501a0.
4
Mechanism of activation of a human oncogene.人类癌基因的激活机制。
Nature. 1982 Nov 11;300(5888):143-9. doi: 10.1038/300143a0.
5
Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus.编码柯斯顿鼠肉瘤病毒p21转化蛋白的癌基因的核苷酸序列。
Science. 1982 Sep 3;217(4563):937-9. doi: 10.1126/science.6287573.
6
Polymorphic DNA region adjacent to the 5' end of the human insulin gene.人类胰岛素基因5'端相邻的多态性DNA区域。
Proc Natl Acad Sci U S A. 1981 Sep;78(9):5759-63. doi: 10.1073/pnas.78.9.5759.
7
Comparative biochemical properties of normal and activated human ras p21 protein.正常与活化的人源ras p21蛋白的比较生化特性
Nature. 1984;310(5979):644-9. doi: 10.1038/310644a0.
8
Structure and expression of amplified cKi-ras gene sequences in Y1 mouse adrenal tumor cells.Y1小鼠肾上腺肿瘤细胞中扩增的cKi-ras基因序列的结构与表达
EMBO J. 1985 May;4(5):1199-203. doi: 10.1002/j.1460-2075.1985.tb03760.x.
9
Concurrent mutations in two different ras genes in acute myelocytic leukemias.急性髓细胞白血病中两个不同ras基因的并发突变。
Nucleic Acids Res. 1987 Jul 24;15(14):5669-80. doi: 10.1093/nar/15.14.5669.
10
Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation.一种显示鳞状和腺性分化特征的新型人膀胱癌细胞系的建立与鉴定
Int J Cancer. 1988 Jan 15;41(1):74-82. doi: 10.1002/ijc.2910410115.